CombinatoRx, Incorporated (CRXX) Says Arthritis Drug Misses ... - PipelineReview.com (press release)
March 27, 2007| CombinatoRx, Incorporated (CRXX) Says Arthritis Drug Misses ... PipelineReview.com (press release), Spain - Comparison of treatment outcomes for CRx-102 (from previously reported results in RA) versus very low dose prednisolone alone (from the study reported here) ... |
Genentech Needs to Gun for Growth - Barron's (subscription)
March 27, 2007 Barron's (subscription) | Genentech Needs to Gun for Growth Barron's (subscription) - Recent expansion of Rituxan into rheumatoid arthritis should provide a near-term boost of growth, particularly if the drug provides benefit to patients in ... |
Trubion Pharmaceuticals, Inc. Reports Fourth Quarter and Year ... - PharmaLive.com (press release)
March 27, 2007| Trubion Pharmaceuticals, Inc. Reports Fourth Quarter and Year ... PharmaLive.com (press release), PA - ... for its lead product candidate, TRU-015, which is currently being tested in a Phase IIb clinical trial for the treatment of rheumatoid arthritis. ... Trubion Pharmaceuticals, Inc. Reports Fourth Quarter and Year ... |
Emerging and Recently Launched Rheumatoid Arthritis Therapies Will ... - Drug Newswire (press release)
March 27, 2007| Emerging and Recently Launched Rheumatoid Arthritis Therapies Will ... Drug Newswire (press release), CT - ... and recently launched therapies Amgen/Wyeth's Enbrel will remain the clinical gold standard for the treatment of rheumatoid arthritis through 2015. ... |
eclinical Update - Debio-0512 Therapeutic Vaccine for the ... - Drug Newswire (press release)
March 27, 2007| eclinical Update - Debio-0512 Therapeutic Vaccine for the ... Drug Newswire (press release), CT - ... an effective approach for the treatment of TNFa-dependent inflammatory pathologies including rheumatoid arthritis and Crohn's disease," said Professor ... |
EntreMed to Present at Cowen and Company 27th Annual Health Care ... - Drug Newswire (press release)
March 27, 2007| EntreMed to Present at Cowen and Company 27th Annual Health Care ... Drug Newswire (press release), CT - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
EntreMed to Present at the 6th Annual North America Forum for ... - Drug Newswire (press release)
March 27, 2007| EntreMed to Present at the 6th Annual North America Forum for ... Drug Newswire (press release), CT - ... cell cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. ... |
The Immune Response Corporation Injects First Patient in Trial of ... - Drug Newswire (press release)
March 27, 2007| The Immune Response Corporation Injects First Patient in Trial of ... Drug Newswire (press release), CT - NeuroVax(TM) may represent a significant advance in the treatment of MS, which affects more than 2.5 million people worldwide, including more than 400000 in ... |
UCB Provides Update On CIMZIA(TM) For Crohn's Disease And ... - Medical News Today (press release)
March 27, 2007| UCB Provides Update On CIMZIA(TM) For Crohn's Disease And ... Medical News Today (press release), UK - UCB plans to file a Biologics License Application (BLA) with the FDA for CIMZIATM in the treatment of rheumatoid arthritis by year end 2007. ... |
European Union CHMP Recommends Approval of First and Only Biologic ... - PipelineReview.com (press release)
March 27, 2007| European Union CHMP Recommends Approval of First and Only Biologic ... PipelineReview.com (press release), Spain - REMICADE treatment is to be initiated and supervised by qualified physicians experienced in the diagnosis and treatment of rheumatoid arthritis, ... |